Literature DB >> 2554074

Upregulation of adrenergic beta receptor subtypes in the senescent rat heart.

N Tumer1, W T Houck, J Roberts.   

Abstract

Beta receptors in older hearts respond to procedures which cause upregulation (N. Tumer et al., J. Gerontol., 1989, in press). To determine whether a particular beta receptor subtype is responsible for the development of upregulation as a function of age, we studied the ratio of beta 1- to beta 2-adrenergic receptors in the membrane preparations from the ventricles of Fischer-344 hearts at 6 and 24 months of age. The animals were injected with 6-hydroxydopamine hydrobromide (6-OHDA) (2 x 50 mg/kg, i.v.) on days 1 and 8 and they were decapitated on day 15. The depletion of norepinephrine in the heart was about 86% in each age group. [125I]iodopindolol (IPIN) was used as the radioligand at the final concentration of 110 pM. Inhibition of specific IPIN binding was studied by adding ICI 89,406 (beta 1-selective antagonist) and ICI 118,551 (beta 2-selective antagonist) at 25 pM to 40 microM. The relative proportions of the beta receptor subtypes were determined using a competition radioligand selective binding and computer modeling technique. The ventricles contained about 67% beta 1 and 33% beta 2-adrenergic receptors in hearts isolated from 6- and 24-month old rats; the ratio remained the same in sympathectomized animals. These data suggest that both subtypes of cardiac adrenergic receptors participate in the response to chemical denervation by 6-OHDA regardless of age.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554074     DOI: 10.1016/0047-6374(89)90074-2

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  4 in total

Review 1.  Beta-adrenergic function in aging. Basic mechanisms and clinical implications.

Authors:  P J Scarpace; N Tumer; S L Mader
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

2.  Cardiac beta-adrenoceptor binding characteristics with age following adrenal demedullation.

Authors:  N Tumer; W T Houck; C Boehm; J Roberts
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases.

Authors:  R P Xiao; E D Tomhave; D J Wang; X Ji; M O Boluyt; H Cheng; E G Lakatta; W J Koch
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

4.  Post-receptor defect accounts for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes.

Authors:  J A Buczek-Thomas; S R Jaspers; T B Miller
Journal:  Mol Cell Biochem       Date:  1992-11-04       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.